OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells $6,352,772.69 in Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) major shareholder Squadron Capital Llc sold 302,369 shares of the firm’s stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $21.01, for a total value of $6,352,772.69. Following the completion of the sale, the insider directly owned 6,201,764 shares in the company, valued at $130,299,061.64. The trade was a 4.65% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Squadron Capital Llc also recently made the following trade(s):

• On Wednesday, September 2nd, Squadron Capital Llc sold 22,500 shares of OrthoPediatrics stock. The stock was sold at an average price of $23.35, for a total value of $525,375.00.
• On Friday, August 28th, Squadron Capital Llc sold 326,700 shares of OrthoPediatrics stock. The shares were sold at an average price of $23.04, for a total value of $7,527,168.00.
• On Tuesday, September 1st, Squadron Capital Llc sold 10,131 shares of OrthoPediatrics stock. The shares were sold at an average price of $23.10, for a total transaction of $234,026.10.
• On Wednesday, August 26th, Squadron Capital Llc sold 18,000 shares of OrthoPediatrics stock. The shares were sold at an average price of $24.28, for a total transaction of $437,040.00.
• On Tuesday, August 25th, Squadron Capital Llc sold 16,300 shares of OrthoPediatrics stock. The shares were sold at an average price of $24.74, for a total transaction of $403,262.00.
• On Monday, August 24th, Squadron Capital Llc sold 4,000 shares of OrthoPediatrics stock. The stock was sold at an average price of $25.75, for a total transaction of $103,000.00.

OrthoPediatrics Trading Down 0.6%

NASDAQ:KIDS opened at $21.56 on Friday. The company has a 50-day moving average price of $21.97 and a 200-day moving average price of $19.02. The stock has a market cap of $562.93 million, a price-to-earnings ratio of -12.83 and a beta of 0.99. The company has a current ratio of 4.78, a quick ratio of 2.17 and a debt-to-equity ratio of 0.28. OrthoPediatrics Corp. has a 12 month low of $14.42 and a 12 month high of $26.74.

OrthoPediatrics (NASDAQ:KIDS) last announced its quarterly earnings results on Tuesday, August 4th. The company reported ($0.26) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.30) by $0.04. OrthoPediatrics had a negative net margin of 15.72% and a negative return on equity of 8.10%. The company had revenue of $70.51 million for the quarter, compared to analysts’ expectations of $68.21 million. Equities analysts predict that OrthoPediatrics Corp. will post -1.14 EPS for the current year.

Institutional Investors Weigh In On OrthoPediatrics

Hedge funds and other institutional investors have recently bought and sold shares of the business. Squarepoint Ops LLC increased its stake in shares of OrthoPediatrics by 95.0% during the second quarter. Squarepoint Ops LLC now owns 195,468 shares of the company’s stock valued at $3,739,000 after purchasing an additional 95,230 shares in the last quarter. Waverly Advisors LLC boosted its position in shares of OrthoPediatrics by 6.7% in the 2nd quarter. Waverly Advisors LLC now owns 12,366 shares of the company’s stock worth $237,000 after purchasing an additional 775 shares in the last quarter. California State Teachers Retirement System grew its stake in shares of OrthoPediatrics by 397.1% in the 2nd quarter. California State Teachers Retirement System now owns 4,553 shares of the company’s stock worth $87,000 after buying an additional 3,637 shares during the last quarter. Nantahala Capital Management LLC purchased a new stake in shares of OrthoPediatrics in the 2nd quarter worth approximately $4,636,002. Finally, Grandeur Peak Global Advisors LLC bought a new position in OrthoPediatrics during the 2nd quarter valued at approximately $954,000. Hedge funds and other institutional investors own 69.05% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. TD Cowen reissued a “buy” rating on shares of OrthoPediatrics in a research report on Monday, June 15th. Needham & Company LLC lifted their price target on OrthoPediatrics from $30.00 to $35.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Weiss Ratings upgraded OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, August 5th. Piper Sandler reaffirmed an “overweight” rating and issued a $25.00 price target (up from $22.00) on shares of OrthoPediatrics in a research note on Wednesday, August 5th. Finally, Truist Financial set a $22.00 price objective on OrthoPediatrics in a report on Wednesday, August 5th. Nine research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $26.44.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.